Krystal Biotech, Inc. (KRYS)
NASDAQ·Healthcare·Biotechnology
$318.52
-0.94%
Mkt Cap $9.13B
Analyst Ratings
Buy
17
Hold
0
Sell
0
Price Target (12 analysts)
$311.00
Range $224.00 – $371.00
Implied Upside
-2.4%
Consensus $311.00 vs current $318.52
NASDAQ·Healthcare·Biotechnology
$318.52
-0.94%
Mkt Cap $9.13B
Buy
17
Hold
0
Sell
0
Price Target (12 analysts)
$311.00
Range $224.00 – $371.00
-2.4%
Consensus $311.00 vs current $318.52